A20Fmdv2 incorporates a defined binding motif used to study integrin recognition and structural determinants of ligand affinity. Residue diversity shapes solvent interactions and folding behavior. Researchers analyze its conformational states to clarify motif function. Applications span biophysical studies, ligand engineering, and receptor-binding analysis.
CAT No: R2462
CAS No:932699-03-1
Synonyms/Alias:A20FMDV2;932699-03-1;EX-A7450;
A20Fmdv2 is a synthetic peptide designed to target specific integrin receptors, particularly those overexpressed in certain pathological tissues. Characterized by its unique amino acid sequence, A20Fmdv2 demonstrates high binding affinity and selectivity, making it a valuable molecular tool for researchers investigating cell adhesion, migration, and signal transduction. Its robust stability and compatibility with various labeling strategies further enhance its versatility in experimental protocols. The peptide's structure enables conjugation with imaging agents, drugs, or nanoparticles, facilitating its use in a wide array of biomedical research applications. As a result, A20Fmdv2 has garnered significant attention in the fields of molecular imaging, targeted delivery, and integrin biology.
Tumor Targeting and Imaging: A20Fmdv2 is extensively utilized in molecular imaging studies aimed at visualizing integrin-expressing tumors. By conjugating the peptide with fluorescent dyes or radiolabels, researchers can achieve precise localization and real-time monitoring of tumor tissues in preclinical models. This approach leverages the peptide's high specificity for αvβ6 integrin, a biomarker frequently upregulated in malignant cells. The resulting imaging probes enable non-invasive detection and longitudinal assessment of tumor progression, providing critical insights into disease mechanisms and therapeutic responses.
Targeted Drug Delivery: Leveraging its integrin-binding properties, A20Fmdv2 serves as a targeting ligand for the delivery of therapeutic agents directly to pathological tissues. When attached to liposomes, nanoparticles, or other drug carriers, the peptide guides these systems to cells with elevated integrin expression, thereby enhancing the selectivity and efficacy of the delivered payload. This targeted approach minimizes off-target effects and improves therapeutic indices in various disease models, supporting the development of precision medicine strategies.
Cell Migration and Adhesion Studies: The peptide is a powerful tool in cell biology research focused on understanding integrin-mediated adhesion and migration. By modulating integrin activity or serving as a competitive inhibitor, A20Fmdv2 allows scientists to dissect the molecular mechanisms governing cell motility, invasion, and tissue remodeling. These studies are essential for elucidating the roles of integrins in development, wound healing, and pathological processes such as fibrosis and metastasis.
Biosensor Development: A20Fmdv2 is increasingly incorporated into biosensor platforms designed to detect integrin-expressing cells or monitor cellular responses in real time. Immobilizing the peptide on sensor surfaces enables the selective capture and quantification of target cells from complex biological samples. Such biosensors are valuable in both basic research and diagnostic development, offering rapid, sensitive, and specific detection of integrin biomarkers.
Theranostic Applications: The unique combination of targeting and imaging capabilities makes A20Fmdv2 a promising candidate for theranostic research, where diagnosis and therapy are integrated into a single platform. By co-delivering imaging agents and therapeutics, researchers can simultaneously visualize and treat pathological tissues, enabling personalized intervention strategies and real-time monitoring of treatment efficacy.
In summary, A20Fmdv2's high specificity for integrin receptors and its amenability to chemical modification underpin its broad utility in scientific research. Its applications span tumor imaging and targeting, drug delivery, cell biology, biosensor development, and theranostics, reflecting its pivotal role in advancing molecular understanding and innovative technologies in biomedical science. As research in integrin biology and targeted therapeutics continues to evolve, the demand for such versatile peptide tools is expected to grow, further cementing the importance of A20Fmdv2 in the scientific community.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More